Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sloan-Lancaster

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cell|December 2, 1994
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergyJ Sloan-Lancaster, A S Shaw, J B Rothbard, et al.
Cell|March 7, 1998
LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activationW Zhang, J Sloan-Lancaster, J Kitchen, et al.
Immunity|June 1, 1995
Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligandsB D Evavold, J Sloan-Lancaster, K J Wilson, et al.
The Journal of Cell Biology|November 13, 1998
ZAP-70 association with T cell receptor zeta (TCRzeta): fluorescence imaging of dynamic changes upon cellular stimulationJ Sloan-Lancaster, J Presley, J Ellenberg, et al.
Thrombosis and Haemostasis|January 5, 2002
Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cellsY Q Chen, J Sloan-Lancaster, D T Berg, et al.
The Journal of Experimental Medicine|December 31, 1997
Regulation of ZAP-70 intracellular localization: visualization with the green fluorescent proteinJ Sloan-Lancaster, W Zhang, J Presley, et al.
Arthritis and Rheumatism|January 30, 2013
Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trialM C Genovese, S Bojin, I M Biagini, et al.
Arthritis and Rheumatism|February 5, 2010
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept studyM C Genovese, F Van den Bosch, S A Roberson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell|December 2, 1994
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergyJ Sloan-Lancaster, A S Shaw, J B Rothbard, et al.
Cell|March 7, 1998
LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activationW Zhang, J Sloan-Lancaster, J Kitchen, et al.
Immunity|June 1, 1995
Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligandsB D Evavold, J Sloan-Lancaster, K J Wilson, et al.
The Journal of Cell Biology|November 13, 1998
ZAP-70 association with T cell receptor zeta (TCRzeta): fluorescence imaging of dynamic changes upon cellular stimulationJ Sloan-Lancaster, J Presley, J Ellenberg, et al.
Thrombosis and Haemostasis|January 5, 2002
Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cellsY Q Chen, J Sloan-Lancaster, D T Berg, et al.
The Journal of Experimental Medicine|December 31, 1997
Regulation of ZAP-70 intracellular localization: visualization with the green fluorescent proteinJ Sloan-Lancaster, W Zhang, J Presley, et al.
Arthritis and Rheumatism|January 30, 2013
Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trialM C Genovese, S Bojin, I M Biagini, et al.
Arthritis and Rheumatism|February 5, 2010
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept studyM C Genovese, F Van den Bosch, S A Roberson, et al.
Pageof 2